The page is the record's research on the issuer — no analyst, no rating, no view.

Diamyd Medical AB ser. B (SE0005162880) — research page

SE · se-cm-kg/SSME/SE0005162880 · as of 2026-11-06

Identity and listing

The issuer is Diamyd Medical AB ser. B, listed on First North Sweden under ticker SE0005162880. Its ISIN is SE0005162880 and its LEI is 5493003NP2HNQDEKB804. Security type, segment, sector and jurisdiction are not on the record. The issuer is listed and not halted.

fieldvaluesource · read date
nameDiamyd Medical AB ser. Bsource · 2026-11-06
exchangeFirst North Swedensource · 2026-11-06
tickerSE0005162880source · 2026-11-06
ISINSE0005162880source · 2026-11-06
LEI5493003NP2HNQDEKB804source · 2026-11-09
security typenot on the record
segmentnot on the record
sectornot on the record
jurisdictionnot on the record
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 74 filings in the twelve months to 2026-11-06, across 37 filing days. The median gap between filing days is 6.5 days, against a median of 11.0 days for First North Sweden, where the record holds 325 issuers. The latest filing is dated 2026-10-29 and is a Notice to general meeting, 8 days before the record date. The exchange median latency is 7 days. Sector medians are not on the record.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer746.58
exchange median: First North Sweden (325 issuers)21117
datetypecategoryfiling
2026-10-29Notice to general meetingNotice to general meetingKallelse till årsstämma i Diamyd Medical AB
2026-10-07Other information disclosed according to the rules of the ExchangeOther information disclosed according to the rules of the ExchangeYear-End Report 25/26
2026-10-07Other information disclosed according to the rules of the ExchangeOther information disclosed according to the rules of the ExchangeBokslutskommuniké 25/26
2026-09-29Investor NewsInvestor NewsNow published: Retogatein from Diamyd Medical delays the need for insulin by more than five years in the randomized, placebo-controlled diabetes prevention - Immune Tolerance Trial
2026-07-27Other information disclosed according to the rules of the ExchangeOther information disclosed according to the rules of the ExchangeDiamyd Medical ger en uppdatering om lärdomar från interimsanalysen i DIAGNODE-3

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record and its location are not on the record. The market's record does not carry auditor changes.

Events and halts

The record carries no listing, delisting, name change, domicile change or segment move lines, because this register has no lifecycle type map yet. The issuer is listed and not halted.

Orderability

The outcome is not determinable under rule acm-68000/se/mifid-ii-product-governance/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.

rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The record names one research house on the issuer's investor-relations page: DNB Carnegie.

research houseanalystsource · read date
DNB CarnegieMaria Karlsson Osipovaissuer page · 2026-11-12

Open research

The record holds one openly published research note, by Khandaker Partners, dated 2006-07-06.

datepublishernotekind
2006-07-06Khandaker PartnersInitiation of Coverageissuer-sponsored

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. No issuer years are sealed, and the earliest sealed date and the live record start date are not on the record.

Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://firds.esma.europa.eu/firds/ (identity.exchange)
10.2
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.3
https://mcp.se-cm-kg.ai/events/SSME/SE0005162880 (the disclosure lines)
10.4
https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
10.5
https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
10.6
https://www.diamyd.com/docs/Investors.aspx (coverage)
10.7
https://www.diamyd.com/docs/pdf/analys/Diamyd_Medical_060706_Final.pdf (open research)
10.8
https://mcp.se-cm-kg.ai/record/SSME/SE0005162880 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0005162880"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:7b6990fa279e64e1.